News archives

2011

• December 19, 2011: Upsher-Smith Women’s Health Launches “Clinicians Corner” – Women’s Health Portal Designed Exclusively for NPs, PAs, Nurses and Midwives
• December 5, 2011: Upsher-Smith Presents Updated Extended-Release Topiramate Data (USL255) at AES Meeting
• November 28, 2011: Upsher-Smith Launches New Epilepsy-Focused Website at AES Annual Meeting
• October 13, 2011: Survey of Nurse Practitioners Finds Oral Estrogen Therapy is Prescribed More Often than Transdermal and Examines External Influences that Affect Prescribing Practices
• September 30, 2011: University of Minnesota Outstanding Achievement Award Presented to Ken Evenstad
• September 26, 2011: Upsher-Smith Teams Up With The National Eczema Association to Take Action During Eczema Awareness Month
• September 26, 2011: Upsher-Smith Laboratories Presents Extended-Release Topiramate Data (USL255) at ANA Meeting
• August 1, 2011: Upsher-Smith Laboratories Named Manufacturer of the Year by AmerisourceBergen Corporation
• July 25, 2011: Epilepsia online publishes new PK data comparing USL255 to Topamax^®
• July 18, 2011: Upsher-Smith Laboratories Begins Phase III Study of Intranasal Midazolam for Rescue Treatment of Seizure Clusters in Epilepsy Patients
• July 11, 2011: Upsher-Smith launches Trianex™ 0.05% (Triamcinolone Acetonide Ointment)
• April 11, 2011: Phase I Research of Extended-Release Topiramate Shows Less Fluctuation in Plasma Levels
• March 23, 2011: Upsher-Smith Laboratories sponsors family at the National Epilepsy Walk
• February 18, 2011: Upsher-Smith Laboratories Announces Expansion of Voluntary Nationwide Recall
• February 16, 2011: Upsher-Smith Laboratories Announces the Voluntary Nationwide Recall of Jantoven^® Warfarin Sodium Tablets, USP, 3 mg, Due to Mislabeled Bottles
• February 7, 2011: Upsher-Smith Laboratories Introduces Nexa™ Select With More Plant-based DHA Than Any Other Once-Daily Single Gel Capsule Rx Prenatal Vitamin

2010

• December 5, 2010: Data Suggests Positive Pharmacokinetic Results From Phase I Research of Extended-Release Topiramate
• November 15, 2010: Upsher-Smith Laboratories Announces Initiation of Open-Label Extension Study of USL255 (Extended-Release Topiramate) For Adjunctive Treatment of Partial-Onset Epilepsy
• September 30, 2010: Upsher-Smith Laboratories to Hold Customer Appreciation Event at NCPA’s 112th Annual Convention
• August 23, 2010: Upsher-Smith Laboratories to Market Vagifem^® 10 mcg in Exclusive Agreement With Novo Nordisk Inc.
• July 7, 2010: Divigel^® (Estradiol Gel) 0.1% is One of a Newer Generation of Bioidentical Estrogens That is FDA-Approved for Relief of Hot Flashes, Including Night Sweats, From Menopause
• June 28, 2010: Upsher-Smith Adds ITI-111 (Nasal Midazolam) to CNS Pipeline
• June 14, 2010: Upsher-Smith Laboratories Announces Initiation of Phase III Clinical Trial of USL255 (Extended-Release Topiramate) for Adjunctive Treatment of Partial-Onset Epilepsy
• April 12, 2010: Upsher-Smith Laboratories Signs Agreement to Sublicense Tonabersat
• January 27, 2010: Non-Patch, Transdermal Estrogen Products Such as Divigel^® Are Effective Hormone Therapy Alternatives to Oral Estrogen

2009

• December 2, 2009: Upsher-Smith Announces Milestone in Development of CNS Strategy: USL255 (Extended Release Topiramate) Entering Late-Stage Clinical Development for Epilepsy
• October 19, 2009: Danny Cottrell Named 2009 NCPA Willard B. Simmons Independent Pharmacist of the Year.
• May 4, 2009: AmLactin^® Family of Moisturizers Has a New Look
• April 3, 2009: Common Skin Condition May Have 40% of Americans Asking, “What Are Those Little Red Bumps?”
• April 3, 2009: New AmLactin^® Foot Cream Immerses Feet in Moisture
• February 17, 2009: Newly Published Menopause Study: “Bioidentical” and FDA-Approved Divigel^® (estradiol gel) 0.1 Percent Safe and Effective Treatment for Moderate to Severe Hot Flashes Associated With Menopause